Background illustration for clinical trials search

Paid Clinical Trials Louisville

Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Louisville KY, Edgewood KY, Nashville TN, Knoxville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase 2, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Louisville KY, Nashville TN, Ann Arbor MI, Zion IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase 3, Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

for
Small-cell Lung Cancer
Location: Louisville KY, Nashville TN, Sarasota FL, St Louis MO,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07218146

Phase 3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Louisville KY, Cincinnati OH, Hilliard OH, Columbus OH,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase 2, Recruiting

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

for
Extensive Stage Small Cell Lung Cancer
Location: Louisville KY, St Louis MO, Memphis TN, Atlanta GA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037758

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

for
Small Cell Lung Cancer (SCLC),
Location: Louisville KY, Memphis TN, Atlanta GA, Pittsburgh PA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07472517

Phase 3, Recruiting

A Study of ZW251 in Participants With Advanced Solid Tumors

for
Hepatocellular Carcinoma,
Location: Louisville KY, Grand Rapids MI, Hackensack NJ,
Sponsor: Zymeworks BC Inc.

Sex: All

Age: 18+

Code: NCT07164313

Phase 1, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Louisville KY, Lexington KY, Cincinnati OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndrome, Anemia
Location: Louisville KY, Nashville TN, Skokie IL, Wheeling WV,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07422480

Phase 3, Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

for
Lymphoid Malignancies
Location: Louisville KY, Chicago IL, Canton OH, Memphis TN,
Sponsor: AVM Biotechnology Inc

Sex: All

Age: 12 - 70+

Code: NCT04329728

Phase 1, Phase 2, Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Louisville KY, Pittsburgh PA, Madison WI, Iowa City IA,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05482893

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: Louisville KY, Nashville TN, Ann Arbor MI, Atlanta GA,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Hematological Malignancies
Location: Louisville KY, St Louis MO, Ann Arbor MI, Atlanta GA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT04634552

Phase 2, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Louisville KY, Lexington KY, Cincinnati OH,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

Phentermine's Impact on Treatment in Teens

for
Childhood Obesity
Location: Louisville KY, Columbia SC, Kansas City MO,
Sponsor: Russell McCulloh, MD

Sex: All

Age: 12 - 17

Code: NCT07282340

Phase 2, Recruiting

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

for
Diabetes Mellitus, Type 1
Location: Louisville KY, Iowa City IA, Charlottesville VA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 35

Code: NCT07222137

Phase 3, Recruiting

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

for
Carcinoma, Squamous Cell
Location: Louisville KY, Columbia SC, Little Rock AR,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041626

Phase 3, Recruiting

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

for
Carcinoma, Squamous Cell
Location: Louisville KY, Columbia SC, Baltimore MD, Dallas TX,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041613

Phase 3, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Louisville KY, Indianapolis IN, Columbus OH,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase 2, Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for
Cervical Squamous Cell Carcinoma,
Location: Louisville KY, Chicago IL, Fairfax VA, Hackensack NJ,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07169734

Phase 1, Phase 2, Recruiting